Presentation is loading. Please wait.

Presentation is loading. Please wait.

André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures.

Similar presentations


Presentation on theme: "André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures."— Presentation transcript:

1 André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures : CORONARY was funded by a grant from the Canadian Institutes of Health Research (CIHR). CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study Results at 1 Year

2 Benefits and risks of performing CABG surgery on beating heart (off pump) not clearly established. Meta-analyses of 59 trials involving 8961 pts – No differences in major CV outcomes except strokes ROOBY (1 Year) – Primary Outcome: Off-pump is worse (p=0.04) – CV Deaths: Off-pump is worse (p=0.03) Background 2

3 79 centers in 19 countries 4,752 patients recruited between (November 2006 October 2011) Designed, coordinated, managed and data analysed and reported by the Population Health Research Institute, Hamilton Health Sciences and McMaster University in Hamilton, Canada The data was monitored by independent DSMB Funded by Canadian Institutes of Health Research CORONARY Trial Organization 3

4 -Off pump CABG compared to on-pump CABG would reduce major clinical events in short-term (30 Days) -Benefits maintained in long-term (5 yrs) Study Hypotheses 4

5 Inclusion Criteria – Isolated CABG with median sternotomy – One of the following: 1.Peripheral vascular disease 2.Cerebrovascular disease 3.Renal Insufficiency 4.Age ≥ 70 years 5.Age 60 -69 with at least one risk factor (diabetes, urgent revascularization, smoker, LVEF ≤ 35%) 6.Age 55 -59 with at least two of the above risk factors Exclusions – Additional cardiac procedure planned – Contraindications to off-pump or on-pump CABG – Emergency or re-do CABG Inclusion/Exclusion Criteria 5

6 Surgical expertise-based randomization – > 2 years of experience as staff cardiac surgeon and – > 100 cases of one or both techniques – Trainees were not allowed to be primary operators Qualifications of Surgeons 6

7 1 st Co-Primary Outcome Composite of total mortality, stroke, non fatal myocardial infarction, new renal failure at 30 days post randomization results presented ACC 2012 results at 1 year 2 nd Co-Primary Outcome Composite of above outcomes plus repeat coronary revascularization over 5 yrs of follow-up (expected 2016) Primary Outcomes 7

8 Secondary Efficacy Outcomes - Components of 1st co-Primary Outcome - Revascularization Other Outcomes - Recurrent angina, and CV mortality - Quality of life, neurocognitive function Other Outcomes – 1 Year 8

9 1 st Co-Primary Outcome Composite of total mortality, stroke, non fatal myocardial infarction, new renal failure at 30 days post randomization 80% power to detect a 28% risk reduction 2 nd Co-Primary Outcome Composite of above outcomes plus repeat coronary re-revascularization over 5 yrs of follow-up (expected 2016) 90% power to detect a 20% risk reduction Statistical Power 9

10 OFF-PUMP (n = 2375) ON-PUMP (n = 2377) Mean Age (years)67.667.5 Males (%)80.081.7 Prior MI33.835.2 Previous Stroke6.77.8 Peripheral Arterial Disease8.08.2 Congestive Heart Failure5.96.6 Urgent Surgery39.538.1 Euroscore 0 – 2 3 – 5 > 5 28.6 51.7 18.1 27.8 54.2 16.8 Baseline Characteristics 10

11 OFF-PUMP (n = 2375) % ON-PUMP (n = 2377) % Left Main22.120.9 Triple Vessel56.160.4 Double Vessel18.716.4 Single Vessel3.02.1 Baseline Disease – Pre-op Angiogram 11

12 Operation Details 12 4752 Randomized (ITT Analyses) Off PumpOn Pump CABG ≤ 30 days2148 (90.4%)2183(91.8%) Cross-overs184 (7.8%)150 (6.4%) Off Pump % On Pump % RR95% CIp value Incomplete revascularization11.810.01.181.00-1.390.05 Operating room (median hrs)4.04.2<0.001 Initial ventilation (median hrs)9.611.2<0.001

13 1 st Co-Primary Outcome (1 Year) 13 Off Pump % On Pump % Hazard Ratio 95% CI p value Primary Outcome Death, Stroke, MI, Renal Failure 12.113.30.910.77-1.070.24

14 1 st Co-Primary Outcome (1 Year) 14 Off Pump % On Pump % Hazard Ratio 95% CI p value Primary Outcome Death, Stroke, MI, Renal Failure 12.113.30.910.77-1.070.24 Components Death5.15.01.030.80-1.32 Stroke1.51.70.900.57-1.41 Non Fatal MI6.87.50.900.73-1.12 New Renal Failure1.3 0.970.59-1.60

15 Death/MI/Stroke/New Renal Failure at 1 Year 15 HR 0.91 95% CI 0.77-1.07 p value 0.24

16 Other Outcomes at 1 year 16 Off Pump % On Pump % Hazard Ratio 95% CIp value Cardiovascular Mortality4.24.01.030.78-1.370.83 Angina1.00.91.050.58-1.880.87 PCI1.10.81.430.79-2.570.23 Re-do CABG0.30.047.000.86-57.00.07 PCI/Re-do CABG1.40.81.660.95-2.890.07 Primary Outcome per Protocol11.513.20.860.73-1.020.08

17 Primary Outcome between 31 days and 1 Year 17 Off Pump % On Pump % Hazard Ratio 95% CI p value Primary Outcome Death/MI/Stroke/Renal Failure 2.63.20.790.55-1.130.19 Components Death 2.12.30.870.58-1.31 Stroke0.50.60.830.36-1.92 Non Fatal MI0.20.40.500.15-1.65 New Renal Failure0.10.20.500.09—2.71

18 Other Outcomes between 31 days and 1 Year 18 Off Pump % On Pump % Hazard Ratio 95% CIp value Cardiovascular Mortality1.5 1.060.65-1.730.82 Angina0.80.71.130.56-2.260.74 PCI0.70.61.150.55-2.410.72 Re-do CABG<0.100.99 PCI/Re-do CABG0.70.61.220.59-2.540.59

19 Quality of Life 19

20 Neurocognitive Function 20

21 21 Subgroups (1)

22 Subgroups (2) 22

23 At 1 Year there was no difference between Off pump CABG and On pump CABG: – Primary Outcome – Individual components of the Primary Outcome – Revascularization procedures – Quality of Life – Neurocognitive functions Conclusions 23

24 In experienced hands, both procedures are reasonable options based on mid-term results Implications 24

25 A. Lamy (Co-PI)P.J. DevereauxJ. Murkin D.P. TaggartD. PrabhakaranR.J. Novick A.R. AkarS.E. FremesE. Paolasso A. AvezumS. HuL. Piegas R. CartierF. LanasZ. Straka S. ChocronP.J. LopezS. Yusuf (co-PI) Steering Committees 25

26 Final Recruitment by Country 4752 patients from 79 sites in 19 countries 26 Argentina (257) Canada (830) Brazil (358) Netherlands (27) Sweden (56) United Kingdom (227) France (4) Italy (48) USA (68) Czech Republic (298) Estonia (91) Turkey (132) Ukraine (11) Colombia (57) Australia (29) Uruguay (34) China (781) India (1307) Chile (137)

27 27


Download ppt "André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures."

Similar presentations


Ads by Google